Herndon and Trainees Featured in EyeNet - The Power of Representation in Ophthalmology
Duke Glaucoma Division Chief and Professor of Ophthalmology, Leon W.
Surface Ophthalmics Announces First Patient Dosed in Phase II Trial for SURF-200 for Acute Dry Eye
SURF-200 leverages the proven Klarity vehicle and betamethasone corticosteroid to treat acute dry eye
Duke Ophthalmology Represented During 44th Virtual Annual Macula Society Meeting
We are proud to report that Duke Ophthalmology was well represented during the 44th Virtual Annual Macula Society Meeting held February 6-7, 2021.
Is Vitreoretinal Surgery Safe for Patients with COVID-19?
Advances in Treating Progressive, Blindness-Inducing Inherited Retinal Diseases
As the niche field of gene augmentation therapy for inherited retinal diseases (IRDs) grows in clinical interest, Duke is participating in the research and testing of the latest, more targeted appr
Intraocular Lens Exchange: Causes, Complications, Considerations
Q&A with corneal specialist, eye surgeon
Alekseev Receives Foundation Fighting Blindness Clinical/Research Fellowship Award
Congratulations to Medical Retina Fellow Oleg Alekseev, MD, PhD on receiving the Foun
Cataract surgery in infancy increases glaucoma risk
NIH-funded clinical trial shows risk is similar whether or not a cloudy lens is replaced with a lens implant.
AGS Webinar Series Part II: A Question of Color: Where Do We Go from Here?
The American Glaucoma Society will host the second webinar of a two-part series, Tackling Social Injustice and Healthcare Disparities.
